SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Xuefen Li, Xia Liu, Li Tian, Yu Chen, Cytokine-Mediated Immunopathogenesis of Hepatitis B Virus Infections, Clinical Reviews in Allergy & Immunology, 2014,

    CrossRef

  2. 2
    Hamid Ullah Wani, Saad Al Kaabi, Manik Sharma, Rajvir Singh, Anil John, Moutaz Derbala, Muneera J. Al-Mohannadi, High Dose of Lamivudine and Resistance in Patients with Chronic Hepatitis B, Hepatitis Research and Treatment, 2014, 2014, 1

    CrossRef

  3. 3
    EunYoung Ze, Eun Kyung Baek, Jong Jin Lee, Han Wook Chung, Dae Geon Ahn, Hwan Jun Cho, Jae Cheol Kwon, Hyung Joon Kim, HyunWoong Lee, Long-term outcomes of two rescue therapies in lamivudine-refractory patients with chronic hepatitis B: combined lamivudine and adefovir, and 1-mg entecavir, Clinical and Molecular Hepatology, 2014, 20, 3, 267

    CrossRef

  4. 4
    Mi Na Kim, Chun Kyon Lee, Sang Hoon Ahn, Sangheun Lee, Seung Up Kim, Do Young Kim, Hyon Suk Kim, Kwang-Hyub Han, Chae Yoon Chon, Jun Yong Park, Maintaining remission in lamivudine-resistant patients with a virological response to adefovir add-on lamivudine after stopping lamivudine therapy, Liver International, 2014, 34, 10
  5. 5
    Tomoko Kurita, Tomomi Kitaichi, Takako Nagao, Toshiyuki Miura, Yoshifumi Kitazono, Safety analysis of Epzicom® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan, Pharmacoepidemiology and Drug Safety, 2014, 23, 4
  6. 6
    Tsurng-Juhn Huang, Bo-Hon Chou, Cheng-Wen Lin, Jen-Hsien Weng, Chang-Hung Chou, Li-Ming Yang, Shwu-Jiuan Lin, Synthesis and antiviral effects of isosteviol-derived analogues against the hepatitis B virus, Phytochemistry, 2014, 99, 107

    CrossRef

  7. 7
    Lazaros A. Poultsides, Yan Ma, Alejandro Gonzalez Della Valle, Ya-Lin Chiu, Thomas P. Sculco, Stavros G. Memtsoudis, In-Hospital Surgical Site Infections after Primary Hip and Knee Arthroplasty — Incidence and Risk Factors, The Journal of Arthroplasty, 2013, 28, 3, 385

    CrossRef

  8. 8
    Yu-Chuen Huang, Chii-Ming Jiang, Yu-Jen Chen, Yu-Yawn Chen, Pectinesterase Inhibitor from Jelly Fig (Ficus awkeotsangMakino) Achene Inhibits Surface Antigen Expression by Human Hepatitis B Virus, Evidence-Based Complementary and Alternative Medicine, 2013, 2013, 1

    CrossRef

  9. 9
    Pejman G. Mansourian, Marc G. Ghany, Emmanuel Thomas, Spontaneous Mutations in the HBV Genome and their Clinical Implications, Current Hepatitis Reports, 2013, 12, 2, 79

    CrossRef

  10. 10
    Mahsa Motavaf, Mahsa Motavaf, Seyed Moayed Alavian, Seyed Moayed Alavian, RNA Interference: A Promising Approach for the Treatment of Viral Hepatitis, Hepatitis Monthly, 2012, 12, 1, 7

    CrossRef

  11. 11
    Mahsa Motavaf, Seyed Moayed Alavian, RNA Interference: A Promising Approach for the Treatment of Viral Hepatitis, Hepatitis Monthly, 2012, 12, 1, 7

    CrossRef

  12. 12
    Kisun Ryu, Nam Doo Kim, Seong Il Choi, Cheol Kyu Han, Jeong Hyeok Yoon, Kyoung Tai No, Kyun-Hwan Kim, Baik L. Seong, Identification of novel inhibitors of HCV RNA-dependent RNA polymerase by pharmacophore-based virtual screening and in vitro evaluation, Bioorganic & Medicinal Chemistry, 2009, 17, 8, 2975

    CrossRef

  13. 13
    Adrian R. Levy, Kris V. Kowdley, Uchenna Iloeje, Eskinder Tafesse, Jayanti Mukherjee, Robert Gish, Natalie Bzowej, Andrew H. Briggs, The Impact of Chronic Hepatitis B on Quality of Life: A Multinational Study of Utilities from Infected and Uninfected Persons, Value in Health, 2008, 11, 3
  14. 14
    Robert Gibb, Graeme R. Nimmo, Peter O'Loughlin, Peter Lowe, David Drummond, Detection of HBsAg mutants in a population with a low prevalence of hepatitis B virus infection, Journal of Medical Virology, 2007, 79, 4
  15. 15
    Winnie Yeo, Frankie K. F. Mo, Stephen L. Chan, Nancy W. Y. Leung, Pun Hui, Wai-Yip Lam, Tony S. K. Mok, Kowk C. Lam, Wing M. Ho, Jane Koh, Julian W. Tang, Anthony T. Chan, Paul K. S. Chan, Hepatitis B viral load predicts survival of HCC patients undergoing systemic chemotherapy, Hepatology, 2007, 45, 6
  16. 16
    Rafik Samuel, Robert Bettiker, Byungse Suh, Antiretroviral therapy 2006: Pharmacology, applications, and special situations, Archives of Pharmacal Research, 2006, 29, 6, 431

    CrossRef

  17. 17
    Marzia Montalbano, Guy W. Neff, Management of recurrent viral hepatitis B and C after liver transplantation, Current Gastroenterology Reports, 2006, 8, 1, 60

    CrossRef

  18. 18
    Chang Hong Lee, Soo–Ok Kim, Kwan Soo Byun, Myung Soon Moon, Eun–Ok Kim, Jong Eun Yeon, Wangdon Yoo, Sun Pyo Hong, Predominance of Hepatitis B Virus YMDD Mutants Is Prognostic of Viral DNA Breakthrough, Gastroenterology, 2006, 130, 4, 1144

    CrossRef

  19. 19
    Zhi Chen, Min Zheng, Patents and development of HBV and HCV clinical treatment: from 2001 to April 2005, Expert Opinion on Therapeutic Patents, 2005, 15, 8, 1027

    CrossRef

  20. 20
    A.J. DEMETRIS, MIKE NALESNIK, PARMJEET RANDHAWA, TONG WU, MARIDA MINERVINI, CHI LAI, ZHENGBIN LU, Transplantation of the Liver, 2005,

    CrossRef

  21. 21
    Ian Craig Lawrance, Kevin Murray, Anne Hall, Joseph J.Y. Sung, Rupert Leong, A Prospective Comparative Study of ASCA and pANCA in Chinese and Caucasian IBD Patients, The American Journal of Gastroenterology, 2004, 99, 11, 2186

    CrossRef

  22. 22
    Marion G. Peters, H.W. Hann, Paul Martin, E.Jenny Heathcote, P. Buggisch, R. Rubin, M. Bourliere, K. Kowdley, C. Trepo, D.F. Gray, M. Sullivan, K. Kleber, R. Ebrahimi, S. Xiong, Carol L. Brosgart, Adefovir dipivoxil alone or in combination with lamivudine in patients with lamivudine-resistant chronic hepatitis B1 1The Adefovir Dipivoxil International 461 Study Group includes the following: N. Afdhal (Beth Israel Deaconess Medical Center, Boston, MA); P. Angus (Austin and Repatriation Medical Centre, Melbourne, Australia); Y. Benhamou (Hopital La Pitie Salpetriere, Paris, France); M. Bourliere (Hopital Saint Joseph, Marseille, France); P. Buggisch (Universitaetsklinikum Eppendorf, Department of Medicine, Hamburg, Germany); P. Couzigou (Hopital Haut Leveque, Pessac, France); P. Ducrotte and G. Riachi (Hopital Charles Nicolle, Rouen, France); E. Jenny Heathcote (Toronto Western Hospital, Toronto, Ontario, Canada); H. W. Hann (Jefferson Medical College, Philadelphia, PA); I. Jacobson (New York Presbyterian Hospital, New York, NY); K. Kowdley (University of Washington Hepatology Center, Seattle, WA); P. Marcellin (Hopital Beaujon, Clichy, France); P. Martin (Cedars-Sinai Medical Center, Los Angeles, CA); J. M. Metreau (Centre Hospitalier Universitaire Henri Mondor, Creteil, France); M. G. Peters (University of California, San Francisco, San Francisco, CA); R. Rubin (Piedmont Hospital, Atlanta, GA); S. Sacks (Viridae Clinical Sciences, Inc., Vancouver, Canada); H. Thomas (St. Mary’s Hospital, London, England); C. Trepo (Hopital Hôtel Dieu, Lyon, France); D. Vetter (Hopital Civil, Strasbourg, France); C. L. Brosgart, R. Ebrahimi, J. Fry, C. Gibbs, K. Kleber, J. Rooney, M. Sullivan, P. Vig, C. Westland, M. Wulfsohn, and S. Xiong (Gilead Sciences, Inc., Foster City, CA); D. F. Gray (GlaxoSmithKline, Greenford, Middlesex, England); R. Schilling and V. Ferry (Parexel International, Waltham, MA); and D. Hunt (Covance Laboratories, Princeton, NJ)., Gastroenterology, 2004, 126, 1, 91

    CrossRef

  23. 23
    Brian Custer, Sean D. Sullivan, Thomas K. Hazlet, Uchenna Iloeje, David L. Veenstra, Kris V. Kowdley, Global Epidemiology of Hepatitis B Virus, Journal of Clinical Gastroenterology, 2004, 38, S158

    CrossRef

  24. 24
    Guy W. Neff, Kenneth E. Sherman, Post-transplant hepatitis: HCV and HBV, Current Hepatitis Reports, 2004, 3, 3, 98

    CrossRef

  25. 25
    Magdalena Gora-Gebka, Anna Liberek, Wieslawa Szydlowska-Lysiak, Wanda Bako, Maria Korzon, Predictive value of serum interleukin-6 and interleukin-12 in children with chronic hepatitis b infection treated with interferon alpha, The Pediatric Infectious Disease Journal, 2004, 23, 1, 85

    CrossRef

  26. 26
    Roula B. Qaqish, Keri A. Mattes, David J. Ritchie, Adefovir dipivoxil: A new antiviral agent for the treatment of hepatitis B virus infection, Clinical Therapeutics, 2003, 25, 12, 3084

    CrossRef

  27. 27
    A.B Jain, J.J Fung, Advances in hepatitis B virus infection, Transplantation Proceedings, 2003, 35, 1, 342

    CrossRef

  28. 28
    Maurice R Hilleman, Critical overview and outlook: pathogenesis, prevention, and treatment of hepatitis and hepatocarcinoma caused by hepatitis B virus, Vaccine, 2003, 21, 32, 4626

    CrossRef

  29. 29
    Claire Thomas, Mark Nelson, Justin Stebbing, HIV and Hepatitis B: A Review, AIDS Patient Care and STDs, 2003, 17, 12, 623

    CrossRef

  30. 30
    J.-H. Park, M.-K. Lee, H.-S. Kim, K. L. Kim, E.-W. Cho, Targeted destruction of the polymerized human serum albumin binding site within the preS2 region of the HBV surface antigen while retaining full immunogenicity for this epitope, Journal of Viral Hepatitis, 2003, 10, 1
  31. 31
    Jim A Turpin, The next generation of HIV/AIDS drugs: novel and developmental antiHIV drugs and targets, Expert Review of Anti-infective Therapy, 2003, 1, 1, 97

    CrossRef

  32. 32
    Ramachandra S. Hosmane, Antiviral Agents, Kirk-Othmer Encyclopedia of Chemical Technology,